Compared with the normal mice, the expression levels of FOSB, GPAT3, and RGCC were significantly reduced (Fig. 9A, B and C), while the expression level of RNF43 was significantly increased (Fig. 9D) in the NAFLD mice. Here, GPAT3 is linked to metabolic dysfunction-associated steatotic liver disease.